ZYME Q4 2019 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-93.5% YoY

Gross Profit

-$44M-2318.2% margin

Operating Income

-$74M-3929.2% margin

Net Income

-$72M-3848.9% margin

EPS (Diluted)

$-1.66

QoQ Revenue Growth

-76.1%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$39M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$368M

Total Liabilities

$123M

Stockholders' Equity

$246M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$29M	-93.5%
Gross Profit	-$44M	$15M	-397.1%
Operating Income	-$74M	$9M	-964.1%
Net Income	-$72M	$9M	-879.1%

Revenue Segments

License and Service

$6M100%